| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000089 | Mitotic metaphase | Affects phenotype | PMID:36384894 |
| GO:0003006 | Developmental process involved in reproduction | Affects phenotype | PMID:37471692 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:33173981 |
| GO:0006357 | Regulation of transcription by rna polymerase ii | Increases phenotype | PMID:27478869 |
| GO:0006701 | Progesterone biosynthetic process | Increases phenotype | PMID:28970132 |
| GO:0006703 | Estrogen biosynthetic process | Decreases phenotype | PMID:28970132 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:28849599 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:29162470 |
| GO:0006811 | Monoatomic ion transport | Increases phenotype | PMID:10991979 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:34748853 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:30153466 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:10556781; PMID:11000096; PMID:12477725; PMID:17901126 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:27601420; PMID:28315349 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:11000096 |
| GO:0007133 | Meiotic anaphase i | Increases phenotype | PMID:29458137 |
| GO:0007137 | Meiotic metaphase ii | Increases phenotype | PMID:29458137 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:15800398; PMID:20163289 |
| GO:0007565 | Female pregnancy | Decreases phenotype | PMID:37471692 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:25486513 |
| GO:0008217 | Regulation of blood pressure | Decreases phenotype | PMID:3180492 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:17599374; PMID:19654912; PMID:24062438; PMID:24213142; PMID:24213142; PMID:32088792; PMID:7588483 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:25486513; PMID:29783106; PMID:29783106; PMID:35307500 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:26385866; PMID:29990529; PMID:32949729 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:23314658 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Increases phenotype | PMID:35605701 |
| GO:0010669 | Epithelial structure maintenance | Decreases phenotype | PMID:29699156 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:31566444 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:36277366 |
| GO:0016571 | Histone methylation | Increases phenotype | PMID:24533973 |
| GO:0016573 | Histone acetylation | Increases phenotype | PMID:24533973; PMID:25088689; PMID:25088689 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:25111128 |
| GO:0019953 | Sexual reproduction | Decreases phenotype | PMID:37471692 |
| GO:0030154 | Cell differentiation | Increases phenotype | PMID:11297507; PMID:7588483 |
| GO:0030194 | Positive regulation of blood coagulation | Increases phenotype | PMID:2821645 |
| GO:0030199 | Collagen fibril organization | Decreases phenotype | PMID:20163289 |
| GO:0030520 | Intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:36513145 |
| GO:0032412 | Regulation of monoatomic ion transmembrane transporter activity | Decreases phenotype | PMID:10991979 |
| GO:0033146 | Regulation of intracellular estrogen receptor signaling pathway | Affects phenotype | PMID:26865669 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:25575267 |
| GO:0035847 | Uterine epithelium development | Increases phenotype | PMID:25575267 |
| GO:0042307 | Positive regulation of protein import into nucleus | Decreases phenotype | PMID:24154490 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:28315349 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:34748853; PMID:36277366; PMID:36621641 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:28849599 |
| GO:0045600 | Positive regulation of fat cell differentiation | Decreases phenotype | PMID:26944108 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:35307500 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32949729 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:9303565 |
| GO:0046620 | Regulation of organ growth | Decreases phenotype | PMID:15800398 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:29699156 |
| GO:0048598 | Embryonic morphogenesis | Decreases phenotype | PMID:26385866; PMID:29990529 |
| GO:0048608 | Reproductive structure development | Affects phenotype | PMID:37471692 |
| GO:0048863 | Stem cell differentiation | Decreases phenotype | PMID:31119342 |
| GO:0051298 | Centrosome duplication | Increases phenotype | PMID:36384894 |
| GO:0051306 | Mitotic sister chromatid separation | Increases phenotype | PMID:36384894 |
| GO:0060068 | Vagina development | Affects phenotype | PMID:33476676 |
| GO:0060669 | Embryonic placenta morphogenesis | Affects phenotype | PMID:22733484 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:33173981 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:20815788; PMID:34748853 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:25088689 |
| GO:0097280 | Histamine secretion mediated by immunoglobulin | Affects phenotype | PMID:6422997 |
| GO:0160024 | Leydig cell proliferation | Increases phenotype | PMID:23314658 |
| GO:1902100 | Negative regulation of metaphase/anaphase transition of cell cycle | Increases phenotype | PMID:37247809 |
| GO:1903087 | Mitotic spindle pole body duplication | Affects phenotype | PMID:36384894 |
| GO:1903109 | Positive regulation of mitochondrial transcription | Increases phenotype | PMID:29699156 |
| GO:1903465 | Positive regulation of mitotic cell cycle dna replication | Increases phenotype | PMID:25575267 |
| GO:1904146 | Positive regulation of meiotic cell cycle process involved in oocyte maturation | Increases phenotype | PMID:29458137 |
| GO:2000224 | Regulation of testosterone biosynthetic process | Decreases phenotype | PMID:23620786 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:23873838 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.